Medicare Enrolled

Dr. Iliana Micali, M.D.

Internal Medicine · Lakewood, WA
Low-engagement
7424 BRIDGEPORT WAY W STE 201, Lakewood, WA 98499
2532402110
In practice since 2005 (21 years)
NPI: 1134128788 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Micali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Micali? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Micali

Dr. Iliana Micali is an internal medicine specialist in Lakewood, WA, with 21 years of NPI registration.

Between the years covered by Open Payments, Dr. Micali received a total of $10,371 from 44 pharmaceutical and/or device companies across 357 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Micali is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice $10,371 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$10,371
Total received (2018-2024)
Avg $1,482/year across 7 years
Top 7% in WA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
357
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,272 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,836
2023
$1,579
2022
$1,530
2021
$2,402
2020
$1,029
2019
$1,269
2018
$727

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$343
Dexcom, Inc.
$303
ABBVIE INC.
$170
Lilly USA, LLC
$156
Phathom Pharmaceuticals, Inc.
$154
GlaxoSmithKline, LLC.
$138
Insulet Corporation
$118
Novo Nordisk Inc
$86
Amgen Inc.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
Bayer Healthcare Pharmaceuticals Inc.
$51
MERZ NORTH AMERICA, INC.
$42
Novartis Pharmaceuticals Corporation
$28
Abbott Laboratories
$25
Xeris Pharmaceuticals, Inc.
$23
Janssen Pharmaceuticals, Inc
$23
PFIZER INC.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Top 3 companies account for 44.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,694
GlaxoSmithKline, LLC.
$1,293
Lilly USA, LLC
$853
Novo Nordisk Inc
$848
Boehringer Ingelheim Pharmaceuticals, Inc.
$651
Amgen Inc.
$581
ABBVIE INC.
$568
Biohaven Pharmaceuticals, Inc.
$525
Dexcom, Inc.
$303
Radius Health, Inc.
$271
Janssen Pharmaceuticals, Inc
$242
Insulet Corporation
$225
Bayer HealthCare Pharmaceuticals Inc.
$194
Daiichi Sankyo Inc.
$180
Phathom Pharmaceuticals, Inc.
$154
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$152
Supernus Pharmaceuticals, Inc.
$142
Novartis Pharmaceuticals Corporation
$130
Mylan Specialty L.P.
$128
Bayer Healthcare Pharmaceuticals Inc.
$109
Mannkind Corporation
$104
Merck Sharp & Dohme Corporation
$104
Ascensia Diabetes Care US Inc.
$100
Kowa Pharmaceuticals America, Inc.
$95
PFIZER INC.
$78
Biohaven Pharmaceutical Holding Company Ltd.
$69
Amarin Pharma Inc.
$67
Sunovion Pharmaceuticals Inc.
$60
Xeris Pharmaceuticals, Inc.
$48
AbbVie Inc.
$43
MERZ NORTH AMERICA, INC.
$42
DEXCOM, INC.
$39
Gilead Sciences, Inc.
$37
Merz North America, Inc.
$30
Medtronic, Inc.
$27
Ultragenyx Pharmaceutical Inc.
$26
Abbott Laboratories
$25
Astellas Pharma US Inc
$24
Neurocrine Biosciences, Inc.
$23
SANOFI-AVENTIS U.S. LLC
$19
MAYNE PHARMA COMMERCIAL LLC
$17
US WorldMeds, LLC
$17
Janssen Biotech, Inc.
$16
Teva Pharmaceuticals USA, Inc.
$15
Top 3 companies account for 37.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · BASAGLAR · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · DEXCOM G6 TRANSMITTER · Descovy · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · FARXIGA · FASENRA · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · INGREZZA · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LATUDA · Livalo · Lucemyra/Lofexidine · MOUNJARO · MYRBETRIQ · NUCALA · NURTEC ODT · Omnipod · Otezla · Ozempic · Prolia · QULIPTA · QVAR · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SIMPONI · SOLIQUA · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SYMBICORT · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · TRULANCE · TRULICITY · Tresiba · Tymlos · UBRELVY · VOQUEZNA · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xeomin · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in WA.

Looking for an internal medicine specialist in Lakewood?
Compare internal medicine physicians in the Lakewood area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
661
Per 100K population
71.5
County median income
$96,632
Nearest hospital
ST CLARE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Micali is an internal medicine specialist, with low-engagement industry engagement in the top 7% of WA peers, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Micali receive payments from pharmaceutical companies?
Yes. Dr. Micali received a total of $10,371 from 44 companies across 357 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Micali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →